Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Microsecretory adenocarcinoma (MSA) of the salivary glands is a recently described entity. Due to lack of reported metastases, in 30 cases described until now, the designation as low-grade cancer was so far solely based on demonstration of local tumor invasion and in a single case with perineural invasion. We herein describe the first documented case with local recurrence and hematogenous metastases.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9734237 | PMC |
| http://dx.doi.org/10.1007/s00428-022-03374-9 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Microsecretory Adenocarcinoma of the Buccal Mucosa: A Rare Case Report and Review of Literature.
Int J Surg Pathol
August 2025
Department of Pathology, Binzhou People's Hospital, Shandong Province, Binzhou, China.
Microsecretory adenocarcinoma is a recently recognized low-grade salivary gland malignancy characterized by distinct histomorphological features, a specific immunophenotype, and recurrent gene fusion. This report describes 43-year-old woman with a two-decade history of a right buccal mucosa mass that exhibited recent enlargement, causing functional impairment. Surgical excision revealed a well-demarcated tumor with microcystic and tubular architecture, basophilic luminal secretions, and low proliferative activity (<1 mitotic figure/2mm).
View Article and Find Full Text PDFMicrosecretory adenocarcinoma: simplifying the diagnosis of a recently recognized salivary gland and cutaneous adnexal neoplasm.
Diagn Pathol
April 2025
Oral Pathology Department, Faculty of Dentistry, Alexandria University, Champollion Street, Azarita, Alexandria, 21521, Egypt.
Background: Microsecretory adenocarcinoma (MSA) is a newly identified entity in the WHO classification of salivary gland tumors characterized by MEF2C::SS18 fusion. It was previously considered as adenocarcinoma not otherwise specified (NOS). With the discovery of new gene fusions specifying distinct salivary gland tumors and restricting the diagnosis of adenocarcinoma NOS, five cases of MSA were recognized for the first time using targeted RNA sequencing.
View Article and Find Full Text PDFCytopathology of a Newly Described Salivary Gland Neoplasm: A Case Report of Microsecretory Adenocarcinoma Presenting in the Parotid Gland.
Acta Cytol
December 2024
Division of Anatomical Pathology, Tygerberg Hospital, National Health Laboratory Service, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
Article Synopsis
- * The first reported case of MSA in the parotid gland involved a 48-year-old man whose fine-needle aspiration biopsy (FNAB) showed unique cellular patterns, including multinucleated giant cells and secretory features, alongside supportive histological evidence.
- * MSA should be included in the differential diagnosis for low-grade salivary gland tumors, and accurate diagnosis can be confirmed through cellular analysis, immunohistochemistry
[Clinicopathological and molecular characteristics of microsecretory adenocarcinoma in salivary gland].
Zhonghua Bing Li Xue Za Zhi
October 2024
Department of Oral Pathology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine; College of Stomatology, Shanghai Jiao Tong University; National Center for Stomatology; National Clinical Research Center for Oral Diseases; Shanghai Key Laboratory of Stomatology, Shang
To investigate the clinicopathological, immunohistochemical, and molecular genetic characteristics of microsecretory adenocarcinoma (MSA) of the salivary gland, and to improve the understanding of this rare tumor. Cases originally diagnosed as MSA at the Department of Oral Pathology, the Ninth People's Hospital of Shanghai Jiao Tong University School of Medicine were retrospectively collected. The cases of polymorphous adenocarcinoma and adenocarcinoma, not otherwise specified from January 2000 to January 2020 were reviewed to identify potential misdiagnosed MSA cases.
View Article and Find Full Text PDFUpdate of newly-recognized salivary gland neoplasms: molecular and immunohistochemical findings and clinical importance.
Histopathology
January 2025
Department of Pathology, The University of Chicago, Chicago, IL, USA.
With the advancement of molecular testing and the routine use of immunohistochemical stains, salivary gland tumours previously categorized as adenoma or adenocarcinoma, not otherwise specified, are being reclassified with distinct diagnoses. Newly recognized benign entities include: sclerosing polycystic adenoma, keratocystoma, intercalated duct hyperplasia and adenoma, and striated duct adenoma. Newly recognized malignant salivary gland tumours include: microsecretory adenocarcinoma, sclerosing microcytic adenocarcinoma, and mucinous adenocarcinoma.
View Article and Find Full Text PDF